% | $
Quotes you view appear here for quick access.

Amgen Inc. Message Board

  • wcoastguy2008 wcoastguy2008 Dec 4, 2012 8:28 AM Flag

    Amarantus Bioscience - AMBS

    Currently trading at under two cents:

    Comment(s) regarding Amarantus' MANF technology:

    "The potential of MANF technology has been recognized by some of the biggest names in the biotech space. Just last month, Amarantus announced that it has appointed Amgen Co-Founder Joseph Rubinfeld, PhD to its Corporate Advisory Board. "I believe in MANF," said Dr. Rubinfeld. "I have reviewed a great number of technologies in my 45 year career in the biopharmaceutical field, and I believe that MANF could be one of the biggest successes that I have ever seen... I believe that if we are able to further de-risk MANF with positive toxicology studies and early clinical data, the company's new orphan drug strategy could get MANF to market rather expeditiously." Dr. Rubinfeld went on to add that MANF has the commercial potential to become a blockbuster drug."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
158.19-0.57(-0.36%)1:54 PMEDT